May 29 2023

Cyclica Acquistion by Recursion Pharmaceuticals Closes

May 29,2023 Toronto GreenSky Ventures is proud to announce that one of its portfolio holding companies, Cyclica Inc., was purchased by Recursion Pharmaceuticals (NASDAQ: RXRX) in an all-share deal which was announced on May 8, 2023 and closed on May 25, 2023.  Headquartered in Toronto, Cyclica built a proprietary, early-stage drug discovery platform that provides statistical […]

Feb 13 2023

GreenSky Announces New Name, New Fund And Team Growth

NEW NAME AND NEW FUND GreenSky Capital will now be known as GreenSky Ventures, reflecting the firm’s commitment to investing in high-growth companies and dedicated entrepreneurs in the Canadian market. GreenSky has an excellent track record of Canadian early-stage venture investing, having already returned 167% of the capital raised in its first three vintage funds […]

Oct 31 2022

Mirexus Biotechnologies Completes Sale of Substantially All of Its Assets

October 31, 2022 Guelph, ON – Mirexus Biotechnologies Inc., the manufacturer of PhytoSpherix® (PHX), a corn-derived nanomaterial, has completed the sale of substantially all of its assets over multiple transactions. The largest of these transactions is the sale of Mirexus’ core intellectual property for PHX and its applications in personal care and nutraceuticals to Mibelle […]

Sep 19 2022

ProNavigator Raises $10 Million Growth Investment, Opens Second Headquarters in U.S.

Raleigh, NC, and Kitchener, ON (9/14/22) – ProNavigator, provider of the only purpose-built SaaS knowledge management platform made for insurance, has closed $10 million of growth financing, co-led by Graphite Ventures and previous investor, Luge Capital. Additional financing partners include EDC, Tactico, and CIBC Innovation Banking. GreenSky Capital led ProNavigator’s Seed round and co-led the company’s Series A.   ProNavigator will use this […]

Aug 09 2022

GreenSky and Henkel invest $3.5M in Direct-C Series A Round

(Toronto – August 9, 2022) – The GreenSky Accelerator Fund IV (“GreenSky”) is pleased to announce that it has made an investment in Direct-C Inc. This CDN$3.5M Series A investment round was co-led by GreenSky and Henkel Adhesive Technologies, a leading global provider of maintenance, repair and overhaul (“MRO”) solutions in more than 800 different […]

May 10 2022

Paidiem Closes Oversubscribed Financing Round and Expands Credit Partnerships

(Toronto – May 10, 2022) – Paidiem Payment Solutions Inc. (Paidiem, or the “Company”), an emerging leader in end-to-end solutions for the contingent workforce ecosystem, proudly announces that it has closed an oversubscribed seed financing round.  The investment was led by GreenSky Capital Inc., through the GreenSky Accelerator Fund IV, with participation from NevCaut Ventures and strategic […]

Mar 22 2022

GreenSky Fund IV invests in Wisedocs AI to expand into US

Toronto – March 22, 2021 Wisedocs, which provides machine learning software-as-a-service for medical record processing, has closed an oversubscribed C$4.1 million Seed financing round. The investment was led by Ripple Ventures, with participation from GreenSky Accelerator Fund IV, and angel investors including George A. Papayiannis of Vena Solutions, and startup veteran Tim Lett.  Wisedocs’ seed […]

Feb 17 2022

Pulse Industrial announces a significant investment from SDTC

Toronto – February 17, 2022 GreenSky Capital is pleased to announce that Pulse Industrial Inc. (“Pulse Industrial”) which uses IoT and AI to reduce greenhouse gas emissions and improve safety in industrial plants, has received CAD$3.5M in a new round of non-dilutive funding from Sustainable Development Technology Canada (“SDTC”). With this investment, the Waterloo-based Pulse Industrial will […]

Feb 02 2022

Cyclica recruits big pharma veteran Michael Palovich as Chief Science Officer to advance robust drug discovery pipeline

February 2, 2022 – Toronto, Canada Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline and a portfolio company of GreenSky Capital, welcomes drug discovery veteran Michael (Mike) Palovich as Chief Science Officer, Head of Drug Discovery. Mike brings 24 years of drug discovery experience at […]

Jan 20 2022

Greensky Capital Inc. Announces That the Greensky Accelerator Fund IV Has Led a Cad$1.85m Financing Round in Funnelytics Inc.

Toronto – January 20, 2021 GreenSky Capital Inc. (“GreenSky”) is very pleased to announce that the GreenSky Accelerator Fund IV, LP has led a CAD$1.85M financing round in Funnelytics Inc. The oversubscribed round included investment from MaRS IAF and angel investors from the GreenSky President’s Club.  Funnelytics enables small to medium sized businesses to visualize the […]